143 filings
Page 4 of 8
424B4
zcwhtz1kq9y qkamxz
25 Apr 23
Prospectus supplement with pricing info
7:45pm
EFFECT
xzqo63k3 vo
25 Apr 23
Notice of effectiveness
12:15am
CORRESP
sp7p1px
21 Apr 23
Correspondence with SEC
12:00am
CORRESP
s9ya0tm
21 Apr 23
Correspondence with SEC
12:00am
CORRESP
9t4zn7aggd c6g
21 Apr 23
Correspondence with SEC
12:00am
CORRESP
gblgggrf rat8y95oo
21 Apr 23
Correspondence with SEC
12:00am
FWP
ahfgqfkxgtjy
20 Apr 23
Free writing prospectus
9:38am
8-K
hixs3gw2ycdogw0xlqsk
20 Apr 23
MAIA Biotechnology Reports Preliminary Survival Data in Part A of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:43am
DEF 14A
072aw77m7puhz5raf86j
19 Apr 23
Definitive proxy
4:06pm
FWP
l43ui
18 Apr 23
Free writing prospectus
3:08pm
8-K
w1xd44o
18 Apr 23
MAIA Biotechnology Announces Excellent
11:39am
CORRESP
jmiirhbi4686e6r
18 Apr 23
Correspondence with SEC
12:00am
CORRESP
551v00bm0jq34
18 Apr 23
Correspondence with SEC
12:00am
FWP
2yi83q5 l29x4
11 Apr 23
Free writing prospectus
8:30am
8-K
t6yq9
11 Apr 23
MAIA Biotechnology Reports Positive Topline Data from Part A Safety Lead-In of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:15am
FWP
gftqlcpka45mfi5vxt
6 Apr 23
Free writing prospectus
6:24pm
10-K
kc3to1
24 Mar 23
Annual report
4:55pm